WHO

Billionaires Pony Up More Funds in Fight to Eradicate Polio

Michael Bloomberg, Ray Dalio lead $70 million infusion into effort backed by Gates Foundation
Article

Originally posted on Wall Street Journal

Bill Gates is getting help from some fellow billionaire philanthropists as he and other health leaders work to overcome setbacks that have delayed the eradication of polio despite a recent sharp decline in the number of cases.

Dr. Margaret Chan & Michael Bloomberg: Political Will Needed to Win Fight Against Noncommunicable Diseases

Blog

Originally posted on WHO

Our modern way of life is a major cause of many noncommunicable diseases (NCDs). Initially lifestyle diseases of industrialized countries, they have long since reached developing countries and lead to serious consequences and tremendous costs for health care systems worldwide. Above all, the implementation of sustainable solutions calls for political action.

Mike Bloomberg Co-Hosts a Twitter Chat on WHO's Work to Reduce Noncommunicable Diseases

Article

Originally posted on Storify.com.

Mike Bloomberg Co-Hosts a Twitter Chat on WHO's Work to Reduce Noncommunicable Diseases - 10AM, Thursday 8/25/2016.

Mike Bloomberg co-hosted a #BeatNCDs Twitter chat with the WHO's Dr. Etienne Krug, answering questions on his recent appointment as the WHO Global Ambassador for Noncommunicable Diseases and the organization's expanding effort to reduce preventable death and injury from NCDs worldwide.

Sanofi Pasteur to Leverage Its Strong Vaccine Legacy in Hunt for Zika Vaccine

- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
Press Release

LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.

Novartis Foundation Commemorates World Leprosy Day with its Continued Efforts to go the Last Mile Toward Elimination

2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease
Summary: 
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease
Press Release
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease

Sodexo and Global Technology Partner SureWash Join Forces to Combat Health Care Acquired Infections

Press Release

GAITHERSBURG, Md., October 29, 2015 /3BL Media/ - Sodexo, a leading provider of integrated facilities management and food service operations, announced a partnership today with SureWash, maker of a mobile, automated, interactive hand hygiene training and assessment system.

Sanofi to Receive “Patent for Humanity” Award at White House

U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
Press Release

BRIDGEWATER, NJ, April 15, 2015 /3BL Media/ – Sanofi announced today that the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO) named the company one of 10 recipients of its prestigious “Patent for Humanity” award. Sanofi is being recognized for its patent that covers an innovative chemical and industrial process for producing semi-synthetic artemisinin utilized in the production of anti-malarial artemisinin-based combination therapies.

Symantec Signs the UN Global Compact’s Business Action Pledge on Ebola Elimination

Blog

Just a few days ago, US President Barack Obama announced plans to withdraw most of the troops from West Africa after a 10-month long military mission to help contain the Ebola virus. The outbreak has been significantly contained from 1,000 new cases a week to roughly 150 a week. However, the fight is far from over.

Global Health Investment Fund Leads $7.5 Million Partnership to Boost Access to Low-Cost Oral Cholera Vaccine

Press Release

SEOUL August 27, 2014 /3BL Media/ - The Global Health Investment Fund (“GHIF”), an innovative financing vehicle structured by JPMorgan Chase & Co.

Antibiotics Resistance: it’s not "what if" it’s when

Blog

What would happen if you got an infection and there was no effective antibiotic available to treat it?  The World Health Organization (WHO) says this is no longer a “what if” scenario, it’s already happening in every region of the world.

Pages

Subscribe to WHO